Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.
作者信息
Goodman Brent P, Gupta Fiona
机构信息
Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Movement Disorders Center, Hackensack University Medical Center, Hackensack, NJ, USA.
出版信息
Clin Auton Res. 2017 Jul;27(Suppl 1):21-23. doi: 10.1007/s10286-017-0432-8. Epub 2017 Jun 19.
Abstract
摘要
相似文献
1
Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.在一名多系统萎缩患者中定义用屈昔多巴成功治疗神经源性直立性低血压。
Clin Auton Res. 2017 Jul;27(Suppl 1):21-23. doi: 10.1007/s10286-017-0432-8. Epub 2017 Jun 19.
2
Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.调整屈昔多巴治疗帕金森病患者神经源性直立性低血压
Clin Auton Res. 2017 Jul;27(Suppl 1):17-19. doi: 10.1007/s10286-017-0431-9. Epub 2017 Jun 19.
3
Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.在患有神经源性直立性低血压和帕金森病的患者中，将屈昔多巴添加到氟氢可的松或米多君中。
Clin Auton Res. 2017 Jul;27(Suppl 1):29-31. doi: 10.1007/s10286-017-0434-6. Epub 2017 Jul 3.
4
Effectiveness of droxidopa compared to midodrine in standing blood pressure and orthostatic tolerance in adults with neurogenic orthostatic hypotension: a systematic review protocol.在患有神经源性直立性低血压的成年人中，与米多君相比，屈昔多巴对站立血压和直立耐受性的有效性：一项系统评价方案
JBI Database System Rev Implement Rep. 2017 Sep;15(9):2287-2294. doi: 10.11124/JBISRIR-2016-003306.
5
Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.多重用药：使用屈昔多巴治疗一名帕金森病合并2型糖尿病患者的神经源性直立性低血压。
Clin Auton Res. 2017 Jul;27(Suppl 1):33-34. doi: 10.1007/s10286-017-0435-5. Epub 2017 Jul 3.
6
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.滴定屈昔多巴以最大化帕金森病合并神经源性直立性低血压患者的症状获益。
Clin Auton Res. 2017 Jul;27(Suppl 1):15-16. doi: 10.1007/s10286-017-0430-x. Epub 2017 Jul 11.
7
New developments in the management of neurogenic orthostatic hypotension.神经源性直立性低血压管理的新进展。
Curr Cardiol Rep. 2014 Nov;16(11):542. doi: 10.1007/s11886-014-0542-z.
8
Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease.帕金森病患者疑似神经源性直立性低血压的鉴别诊断。
Clin Auton Res. 2017 Jul;27(Suppl 1):5-7. doi: 10.1007/s10286-017-0427-5. Epub 2017 Jul 3.
9
L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.L-苏糖型二羟基苯丝氨酸（L-苏糖型-DOPS；屈昔多巴）用于治疗神经源性直立性低血压：一项针对多系统萎缩和单纯自主神经功能衰竭的多国、多中心、剂量范围研究。
Clin Auton Res. 2001 Aug;11(4):235-42. doi: 10.1007/BF02298955.
10
Droxidopa (Northera) for neurogenic orthostatic hypotension.屈昔多巴（诺特罗）用于神经源性直立性低血压。
Med Lett Drugs Ther. 2015 Jun 22;57(1471):92-3.
引用本文的文献
1
Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.神经原性直立性低血压的临床试验：终点、陷阱和挑战的综合评价。
Semin Neurol. 2020 Oct;40(5):523-539. doi: 10.1055/s-0040-1713846. Epub 2020 Sep 9.
2
Orthostatic Hypotension in Parkinson Disease.帕金森病患者的直立性低血压。
Clin Geriatr Med. 2020 Feb;36(1):53-67. doi: 10.1016/j.cger.2019.09.002. Epub 2019 Sep 6.
3
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.遗传性转甲状腺素蛋白淀粉样变性的直立性低血压：流行病学、诊断和治疗。
Clin Auton Res. 2019 Sep;29(Suppl 1):33-44. doi: 10.1007/s10286-019-00623-x. Epub 2019 Aug 26.
4
Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.帕金森病和其他突触核蛋白病自主神经功能障碍的治疗。
Mov Disord. 2018 Mar;33(3):372-390. doi: 10.1002/mds.27344.
本文引用的文献
1
Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.盐酸米多君对症状性直立性低血压的临床疗效：一项4期、双盲、安慰剂对照、随机倾斜试验研究
Clin Auton Res. 2016 Aug;26(4):269-77. doi: 10.1007/s10286-016-0363-9. Epub 2016 Jul 2.
2
Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.多巴丝肼治疗神经源性直立性低血压的安全性和有效性的荟萃分析。
Clin Auton Res. 2016 Jun;26(3):171-80. doi: 10.1007/s10286-016-0349-7. Epub 2016 Mar 7.
3
Supine hypertension in Parkinson's disease and multiple system atrophy.帕金森病和多系统萎缩中的仰卧位高血压
Clin Auton Res. 2016 Apr;26(2):97-105. doi: 10.1007/s10286-015-0336-4. Epub 2016 Jan 22.
4
Droxidopa in neurogenic orthostatic hypotension.屈昔多巴治疗神经源性直立性低血压。
Expert Rev Cardiovasc Ther. 2015;13(8):875-91. doi: 10.1586/14779072.2015.1057504. Epub 2015 Jun 19.
5
Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.吡啶斯的明治疗神经源性直立性低血压[高血压的校正]——一项随访调查研究。
Clin Auton Res. 2005 Feb;15(1):51-3. doi: 10.1007/s10286-005-0225-3.
6
The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure.去氨加压素对自主神经功能衰竭患者夜间多尿、夜间体重减轻及晨起体位性低血压的影响。
Br Med J (Clin Res Ed). 1986 Aug 9;293(6543):353-4. doi: 10.1136/bmj.293.6543.353.
Zotero 插件